Medical versus surgical abortion: A survey of knowledge and attitudes among abortion clinic patients

Women's Health Issues

Volumn 9, Issue 3, 1999, Pages 143-154

  Virgo, Katherine S ^a   Carr, T R ^b   Hile, Allison ^c   Virgo, John M ^d   Sullivan, George M ^d   Kaikati, Jack G ^d  

^a SAINT LOUIS UNIVERSITY   (United States)

^b Dept Pub Admin Plcy Anal S I ^*  (United States)

^c The Hope Clinic for Women Ltd   (United States)

^d SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIFEPRISTONE;

ABORTION; ARTICLE; CONFUSION; CONTRACEPTION; DRUG CHOICE; EDUCATION; FEMALE; HEALTH EDUCATION; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PREGNANCY; PUBLIC OPINION; RACE DIFFERENCE; RELIGION; SCIENCE; SEXUAL BEHAVIOR; UNITED STATES;

ABORTIFACIENT AGENTS; ABORTION SEEKERS; ABORTION SURVEYS; ABORTION, DRUG INDUCED; ABORTION, INDUCED; AMERICAS; ATTITUDE--WOMEN; BEHAVIOR; BIOLOGY; CLINICAL APPROACH/SOURCE; DEVELOPED COUNTRIES; EMPIRICAL APPROACH; ENDOCRINE SYSTEM; FAMILY PLANNING; FERTILITY CONTROL, POSTCONCEPTION; GENETICS AND REPRODUCTION; HORMONE ANTAGONISTS; HORMONES; ILLINOIS; KNOWLEDGE--WOMEN; NORTH AMERICA; NORTHERN AMERICA; PHYSIOLOGY; PREGNANT WOMEN; PSYCHOLOGICAL FACTORS; RESEARCH REPORT; RISKS AND BENEFITS; RU-486; UNITED STATES; WOMEN;

ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADOLESCENT; ADULT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; ILLINOIS; MIFEPRISTONE; PATIENT EDUCATION; PREGNANCY; PREGNANT WOMEN; RISK ASSESSMENT;

EID: 0032973737     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1049-3867(99)00005-5     Document Type: Article

References (28)

1. Henshaw S. Induced abortion a worldwide perspective . Fam Plann Perspect. 18:1986;250-254.
2. Baulieu E.E. An antiprogestin steroid with contragestive activity in women. Baulieu E.E., Segal S.J. The antiprogestin steroid RU 486 and human fertility control. 1985;Plenum Press, New York.
3. David H.P. Acceptability of mifepristone for early pregnancy interruption. Law Med Health Care. 20:1992;188-194.
4. Castle M.A., Coeytaux F.M. RU 486 beyond the controversy implications for health care practice . J Am Med Womens Assoc. 49:1994;156-164.
5. Winikoff B., Ellertson C., Elul B., Sivin I. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Arch Fam Med. 7:1998;360-366.
6. Spitz I.M., Bardin C.W., Benton L., Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med. 338:1998;1241-1247.
7. Schaff E.A., Stadalius L.S., Eisinger S.H., Franks P. Vaginal misoprostol administered at home after mifepristone (RU 486) for abortion. J Fam Pract. 44:1997;353-360.
8. Baird T.L., Pearl M. Potential acceptability of ovulation detection kits and RU 486 at two college campuses. J Am Coll Health. 43:1994;51-56.
9. Rosen A.S., Nystedt L., Bygdeman M., Lundstrom V. Acceptability of a nonsurgical method to terminate very early pregnancy in comparison to vacuum aspiration. Contraception. 19:1979;107-117.
10. Rosen A.S., von Knorring K., Bygdeman M., Christensen N.J. Randomized comparison of prostaglandin treatment in hospital or at home with vacuum aspiration for termination of early pregnancy. Contraception. 29:1984;423-435.
11. 1 analog vaginal pessary for the termination of early pregnancy complications and patient acceptability . Am J Obstet Gynecol. 162:1990;414-417.
12. Tang G.W.K. A pilot study of acceptability of RU 486 and ONO 802 in a Chinese population. Contraception. 44:1991;523-532.
13. Urquhart D.R., Templeton A.A. Psychiatric morbidity and acceptability following medical and surgical methods of induced abortion. Br J Obstet Gynecol. 98:1991;396-399.
14. Legarth J., Peen U.B., Michelsen J.W. Mifepristone or vacuum aspiration in termination of early pregnancy. Eur J Obstet Gynecol Reprod Biol. 41:1991;91-96.
15. Holmgren K. Women's evaluation of three early abortion methods. Acta Obstet Gynecol Scand. 71:1992;616-623.
16. Bachelot A., Cludy L., Spira A. Conditions for choosing between drug-induced and surgical abortions. Contraception. 45:1992;547-559.
17. Grimes D.A., Mishell D.R., David H.P. A randomized clinical trial of mifepristone (RU 486) for induction of delayed menses efficacy and acceptability . Contraception. 46:1992;1-10.
18. Thong K.J., Dewar M.H., Baird D.T. What do women want during medical abortion? Contraception. 46:1992;435-442.
19. Tang G.W.K., Lau O.W.K., Yip P. Further acceptability evaluation of RU 486 and ONO 802 as abortifacient agents in a Chinese population. Contraception. 48:1993;267-276.
20. Henshaw R.C., Naji S.A., Russell I.T., Templeton A.A. Comparison of medical abortion with surgical vacuum aspiration women's preferences and acceptability of treatment . BMJ. 307:1993;714-717.
21. Winikoff B. Acceptability of medical abortion in early pregnancy. Fam Plann Perspect. 27:1995;142-148.
22. Beckman L.J., Harvey S.M. Experience and acceptability of medical abortion with mifepristone and misoprostol among U. S. women. Womens Health Issues. 7:1997;253-262.
23. Castle M.A., Harvey S.M., Beckman L., Coeytaux F., Garrity J.M. Listening and learning from women about mifepristone implications for counseling and health education . Womens Health Issues. 5:1995;130-138.
24. Harvey S.M., Beckman L.J., Castle M.A., Coeytaux F. Knowledge and perceptions of medical abortion among potential users. Fam Plann Perspect. 27:1995;203-207.
25. Winikoff B., Sivin I., Coyaji K.J., et al. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India a comparative trial of mifepristone-misoprostol versus surgical abortion . Am J Obstet Gynecol. 176:1997;431-437.
26. Creinin M.D., Park M. Acceptability of medical abortion with methotrexate and misoprostol. Contraception. 52:1995;41-44.
27. Schaff E.A., Eisinger S.H., Franks P., Kim S.S. Combined methotrexate and misoprostol for early induced abortion. Arch Fam Med. 4:1995;774-779.
28. Creinin M.D., Vittinghoff E., Schaff E., Klaisle C., Darney P.D., Dean C. Medical abortion with oral methotrexate and vaginal misoprostol. Obstet Gynecol. 90:1997;611-616.